Product
Help
Pricing
About
Jobs
Log in
Get started
Concept
Add to collection
Piperacillin/tazobactam
OpenAlex ID:
C2777858937
Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance: A Randomized Clinical Trial
2018
·
Patrick N. A. Harris
, Paul A. Tambyah
, et al.
·
JAMA
·
878
PDF
Piperacillin-Tazobactam for Pseudomonas aeruginosa Infection: Clinical Implications of an Extended-Infusion Dosing Strategy
2007
·
T. P. Lodise
, B. Lomaestro
, et al.
·
Clinical Infectious Diseases
·
571
The Nephrotoxicity of Vancomycin
2017
·
EJ Filippone
, WK Kraft
, et al.
·
Clinical Pharmacology & Therapeutics
·
471
PDF
Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial
2012
·
J. M. Dulhunty
, J. A. Roberts
, et al.
·
Clinical Infectious Diseases
·
439
Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)
2015
·
Florian M Wagenlehner
, Obiamiwe Umeh
, et al.
·
The Lancet
·
418
Emerging Infections in Burns
2009
·
Ludwik K. Branski
, Ahmed Al-Mousawi
, et al.
·
Surgical Infections
·
412
-Lactam/ -Lactam Inhibitor Combinations for the Treatment of Bacteremia Due to Extended-Spectrum -Lactamase-Producing Escherichia coli: A Post Hoc Analysis of Prospective Cohorts
2011
·
J. Rodriguez-Bano
, M. D. Navarro
, et al.
·
Clinical Infectious Diseases
·
400
PDF
Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial
2019
·
Marin H Kollef
, Martin Nováček
, et al.
·
The Lancet Infectious Diseases
·
372
Carbapenem Therapy Is Associated With Improved Survival Compared With Piperacillin-Tazobactam for Patients With Extended-Spectrum β-Lactamase Bacteremia
2015
·
Pranita D. Tamma
, Jennifer H. Han
, et al.
·
Clinical Infectious Diseases
·
350
PDF
Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial
2018
·
Keith S. Kaye
, Tanaya Bhowmick
, et al.
·
JAMA
·
342
PDF
Influence of Renal Function on the Pharmacokinetics of Piperacillin/Tazobactam in Intensive Care Unit Patients During Continuous Venovenous Hemofiltration
2005
·
Alazne Arzuaga
, Javier Maynar
, et al.
·
The Journal of Clinical Pharmacology
·
336
Ceftazidime-Resistant Klebsiella pneumoniae Isolates Recovered at the Cleveland Department of Veterans Affairs Medical Center
1996
·
L. B. Rice
, E. C. Eckstein
, et al.
·
Clinical Infectious Diseases
·
325
Antibiotic use in patients with COVID-19: a ‘snapshot’ Infectious Diseases International Research Initiative (ID-IRI) survey
2020
·
Bojana Beović
, May Doušak
, et al.
·
Journal of Antimicrobial Chemotherapy
·
313
PDF
Empiric Combination Antibiotic Therapy Is Associated with Improved Outcome against Sepsis Due to Gram-Negative Bacteria: a Retrospective Analysis
2010
·
Scott T. Micek
, Emily C. Welch
, et al.
·
Antimicrobial Agents and Chemotherapy
·
309
Clinical Outcomes With Extended or Continuous Versus Short-term Intravenous Infusion of Carbapenems and Piperacillin/Tazobactam: A Systematic Review and Meta-analysis
2012
·
Matthew E. Falagas
, Giannoula S. Tansarli
, et al.
·
Clinical Infectious Diseases
·
308
A Multicenter Randomized Trial of Continuous versus Intermittent β-Lactam Infusion in Severe Sepsis
2015
·
Joel M. Dulhunty
, Jason A. Roberts
, et al.
·
American Journal of Respiratory and Critical Care Medicine
·
301
Ertapenem versus piperacillin/tazobactam for diabetic foot infections (SIDESTEP): prospective, randomised, controlled, double-blinded, multicentre trial
2005
·
Benjamin A Lipsky
, David G Armstrong
, et al.
·
The Lancet
·
289
Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial
2017
·
Manuela Aguilar-Guisado
, Ildefonso Espigado
, et al.
·
The Lancet Haematology
·
270
Antimicrobial therapy of unexplained fever in neutropenic patients
2003
·
H. Link
, A. B�hme
, et al.
·
Annals of Hematology
·
269
Application of Antimicrobial Pharmacodynamic Concepts into Clinical Practice: Focus on β‐Lactam Antibiotics
2006
·
Thomas P. Lodise
, Ben M. Lomaestro
, et al.
·
Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy
·
262
Relationship between Fluoroquinolone Area under the Curve:Minimum Inhibitory Concentration Ratio and the Probability of Eradication of the Infecting Pathogen, in Patients with Nosocomial Pneumonia
2004
·
George L. Drusano
, Sandra L. Preston
, et al.
·
The Journal of Infectious Diseases
·
259
Vancomycin Plus Piperacillin-Tazobactam and Acute Kidney Injury in Adults: A Systematic Review and Meta-Analysis
2017
·
Megan K. Luther
, Tristan T. Timbrook
, et al.
·
Critical Care Medicine
·
257
Augmented renal clearance, low β-lactam concentrations and clinical outcomes in the critically ill: An observational prospective cohort study
2015
·
Angela Huttner
, Elodie Von Dach
, et al.
·
International Journal of Antimicrobial Agents
·
257
Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer
1995
·
A Cometta
, S Zinner
, et al.
·
Antimicrobial Agents and Chemotherapy
·
257
A Randomized, Double-blind, Multicenter Trial Comparing Efficacy and Safety of Imipenem/Cilastatin/Relebactam Versus Piperacillin/Tazobactam in Adults With Hospital-acquired or Ventilator-associated Bacterial Pneumonia (RESTORE-IMI 2 Study)
2020
·
Ivan Titov
, Richard G Wunderink
, et al.
·
Clinical Infectious Diseases
·
256
PDF
Show more works
View as search
Works count:
4,680
Citation count:
74,650
Year
Topic
Type